These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 25027535)
1. Glycopyrrolate for treatment of clozapine-induced sialorrhea in adults. Blissit KT; Tillery E; Latham C; Pacheco-Perez J Am J Health Syst Pharm; 2014 Aug; 71(15):1282-7. PubMed ID: 25027535 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the efficacy and impact on cognition of glycopyrrolate and biperiden for clozapine-induced sialorrhea in schizophrenic patients: a randomized, double-blind, crossover study. Liang CS; Ho PS; Shen LJ; Lee WK; Yang FW; Chiang KT Schizophr Res; 2010 Jun; 119(1-3):138-44. PubMed ID: 20299191 [TBL] [Abstract][Full Text] [Related]
5. Glycopyrrolate for treatment of clozapine-induced sialorrhea in three adolescents. Robb AS; Lee RH; Cooper EB; Siedel JV; Nusrat N J Child Adolesc Psychopharmacol; 2008 Feb; 18(1):99-107. PubMed ID: 18294092 [TBL] [Abstract][Full Text] [Related]
6. Glycopyrrolate for chronic drooling in children. Eiland LS Clin Ther; 2012 Apr; 34(4):735-42. PubMed ID: 22445330 [TBL] [Abstract][Full Text] [Related]
7. Glycopyrrolate in comparison to hyoscine hydrobromide and placebo in the treatment of hypersalivation induced by clozapine (GOTHIC1): study protocol for a randomised controlled feasibility study. Qurashi I; Chu S; Husain N; Drake RJ; Chaudhry I; Deakin JF Trials; 2016 Nov; 17(1):553. PubMed ID: 27871302 [TBL] [Abstract][Full Text] [Related]
8. The Effect of Glycopyrrolate on Nocturnal Sialorrhea in Patients Using Clozapine: A Randomized, Crossover, Double-Blind, Placebo-Controlled Trial. Man WH; Colen-de Koning JC; Schulte PF; Cahn W; van Haelst IM; Doodeman HJ; Egberts TC; Heerdink ER; Wilting I J Clin Psychopharmacol; 2017 Apr; 37(2):155-161. PubMed ID: 28129312 [TBL] [Abstract][Full Text] [Related]
9. Compounded glycopyrrolate is a compelling choice for drooling children: five years of facility experience. Zanon D; Tumminelli C; Galimberti AMC; Torelli L; Maestro A; Barbi E; Maximova N Ital J Pediatr; 2021 Nov; 47(1):222. PubMed ID: 34742343 [TBL] [Abstract][Full Text] [Related]
10. Immediate-release oxybutynin for the treatment of clozapine-induced sialorrhea. Leung JG; Puri NV; Jacobson MJ Ann Pharmacother; 2011 Sep; 45(9):e45. PubMed ID: 21852588 [TBL] [Abstract][Full Text] [Related]
11. Potential use of ipatropium bromide for the treatment of clozapine-induced hypersalivation: a preliminary report. Calderon J; Rubin E; Sobota WL Int Clin Psychopharmacol; 2000 Jan; 15(1):49-52. PubMed ID: 10836287 [TBL] [Abstract][Full Text] [Related]
12. Trihexyphenidyl treatment of clozapine-induced hypersalivation. Spivak B; Adlersberg S; Rosen L; Gonen N; Mester R; Weizman A Int Clin Psychopharmacol; 1997 Jul; 12(4):213-5. PubMed ID: 9347382 [TBL] [Abstract][Full Text] [Related]
13. Sublingual atropine in the treatment of clozapine-induced sialorrhea. Matos Santana TE; Capurso NA; Ranganathan M; Yoon G Schizophr Res; 2017 Apr; 182():144-145. PubMed ID: 27816262 [No Abstract] [Full Text] [Related]